BenevolentAI
successful collaboration with year target collaboration to novel targets for chronic kidney disease and idiopathic pulmonary fibrosis separate data environment established to integrate data into a bespoke knowledge graph and teams working in close collaboration to explore identify and validate targets key milestone reached took novel generated target for into their drug portfolio with further targets to follow deal structure of license fee milestone payments and downstream royalties the vast amount of data available to research scientists is growing exponentially each year by combining disease area and large diverse with leading and machine learning capabilities we can unlock the potential of this wealth of data to improve our understanding of complex disease biology and identify new targets that could treat debilitating diseases president collaboration video pos | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
30 of 42
Related slides by other companies
Investor Presentation
August 2023
Investor Day
June 2022
SPAC
August 2021
Investor Presentation
July 2023
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io